Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

GLP-1 medications like Ozempic and Mounjaro can influence the volume of all-cause hospital admissions and bariatric surgeries, two studies suggest. Researchers at Boston-based Harvard Medical School ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

0001) vs category 1. The proportions reporting reduced ... 46% for first-generation GLP-1s (Saxenda, Trulicity, and Victoza), ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the battle between the pharmaceutical giants providing them — and delves into what ...

It’s also easy to use and requires only one injection per week. Lastly, Victoza is another great alternative to Ozempic. It’s been around for a while and has a proven track record of ...